WHAT IS ENZYME COIN?
Enzyme enables the creation and scaling of your chosen investment strategies, from discretionary and robo to ETFs and market making. The second-generation smart contract-based platform is extensively tested and audited before any mainnet deployment.
What is Enzyme (MLN)?
Formerly known as Melon Protocol, Enzyme Finance is a protocol built on Ethereum (ETH) that allows users to create, manage, and invest in custom crypto asset management tools.
Enzyme aims to decentralize traditional asset management, historically the domain of professional financial advisors and firms. The idea is to reduce entry barriers into asset management with the MLN cryptocurrency, thereby providing access to more global consumers.
For example, managed funds typically require a minimum investment amount and management fees, which can make these wealth tools inaccessible to the average consumer. Today, the capabilities to create asset management funds, requiring significant capital and legal counsel, are also out of reach. Moreover, filing documents for a fund can take years.
At this point, Enzyme aims to create an alternative system. Using the project’s web portal, users can invest in funds and portfolios initiated by other users, and other users can invest in their creations. The Enzyme Finance protocol uses the MLN cryptocurrency to execute various transactions on the platform.
Enzyme Finance, formerly Melon, was built by Melonport, a private company founded in 2016 by former Goldman Sachs Vice President Mona El Isa and mathematician Rito Trinkler.
Between 2017 and 2018, 1,250,000 MLN cryptocurrencies were created and distributed by the Switzerland-based company. Melonport raised $2.9 million in an ICO in 2017. In 2019, after delivering the first version of the Enzyme Finance protocol, Melonport was dissolved and its management was transferred to the Melon Council, a decentralized autonomous organization (DAO).
How to Buy Enzyme Coin?
MLN Coin can be quickly and securely purchased through Binance. #Write2Earn
